Leading Pharma Company Signs Marketing Services Agreement with Dendrite
biz.yahoo.com
Tuesday September 20, 8:00 am ET
Dendrite's Marketing Services Solutions to Help Grow Brand Market Share
BEDMINSTER, N.J.--(BUSINESS WIRE)--Sept. 20, 2005--Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of sales, marketing, clinical and compliance solutions for the life sciences industry, today announced that a leading pharmaceutical company has purchased components of Dendrite's First Source(TM) Integrated Marketing solution suite to help bolster sales and marketing for one of the company's brands .
The company is implementing several components of Dendrite's First Source Integrated Marketing solution suite, including Medical Dialogue(TM), Physician Connect(TM), e-Sampling(TM) and Longitudinal Prescription Data (LPD), thereby leveraging a multitude of marketing channels to create specific marketing strategies by segment, for physicians most likely to prescribe this brand.
Dendrite's Physician Connect is a breakthrough solution that identifies local personal and professional influence patterns and permits manufacturers to leverage these networks. When coupled with LPD this solution provides a very powerful method to create segmentation and prioritization of prescribers to maximize the impact of marketing programs.
The integrated solution also includes Medical Dialogue which provides a multi-disciplinary panel of physician consultants who conduct interactive promotional discussions with healthcare professionals over the telephone. This intervention has shown tremendous impact on defined, high-value prescribers in multiple therapeutic categories.
"Through our partnership to reinvigorate this well-known brand, Dendrite is enabling this customer to stay ahead of its competition and maximize its market opportunity," said Rick Rose, vice president and general manager at Dendrite. |
